Maryam Darvish

579 total citations
33 papers, 431 citations indexed

About

Maryam Darvish is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Maryam Darvish has authored 33 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Maryam Darvish's work include Toxin Mechanisms and Immunotoxins (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Polyomavirus and related diseases (3 papers). Maryam Darvish is often cited by papers focused on Toxin Mechanisms and Immunotoxins (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Polyomavirus and related diseases (3 papers). Maryam Darvish collaborates with scholars based in Iran, United States and Japan. Maryam Darvish's co-authors include Hamed Mirzaei, Samaneh Mazaheri, Milad Ashrafizadeh, Ali Zarrabi, Zahra Bahmanpour, Pooyan Makvandi, Haroon Khan, Michael R. Hamblin, Fatemeh Soleimanifar and Majid Nejati and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Cellular Physiology.

In The Last Decade

Maryam Darvish

30 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam Darvish Iran 12 221 81 59 55 55 33 431
Xiaoqin Yu China 15 262 1.2× 123 1.5× 43 0.7× 35 0.6× 35 0.6× 41 471
Noureldien H. E. Darwish United States 14 246 1.1× 59 0.7× 109 1.8× 75 1.4× 69 1.3× 36 621
Mohsen Rastegari‐Pouyani Iran 11 172 0.8× 85 1.0× 53 0.9× 61 1.1× 23 0.4× 18 424
Anvar Soleimani Iran 12 236 1.1× 73 0.9× 114 1.9× 79 1.4× 80 1.5× 22 536
Jieping Wu China 11 244 1.1× 59 0.7× 42 0.7× 62 1.1× 46 0.8× 43 426
Jinghui Lu China 13 227 1.0× 109 1.3× 110 1.9× 117 2.1× 55 1.0× 45 673
Zheng Qiu China 9 214 1.0× 66 0.8× 134 2.3× 70 1.3× 32 0.6× 21 436
Alessandro Paolini Italy 14 264 1.2× 125 1.5× 64 1.1× 67 1.2× 64 1.2× 24 523
Qianqian Di China 15 304 1.4× 58 0.7× 47 0.8× 158 2.9× 64 1.2× 38 548
Sebastian Reichert Germany 14 349 1.6× 60 0.7× 124 2.1× 46 0.8× 50 0.9× 18 548

Countries citing papers authored by Maryam Darvish

Since Specialization
Citations

This map shows the geographic impact of Maryam Darvish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Darvish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Darvish more than expected).

Fields of papers citing papers by Maryam Darvish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Darvish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Darvish. The network helps show where Maryam Darvish may publish in the future.

Co-authorship network of co-authors of Maryam Darvish

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Darvish. A scholar is included among the top collaborators of Maryam Darvish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Darvish. Maryam Darvish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fedorova, Yu. Yu., et al.. (2025). Study of the association between HIF1A and VEGFA gene polymorphisms and ovarian cancer risk in women from Bashkortostan. Siberian Journal of Oncology. 24(1). 79–91.
2.
Nejati, Majid, et al.. (2024). The Combination of 5-FU and Resveratrol Can Suppress the Growth of Glioblastoma Cells Through Downregulation of TRPM2 and β-Catenin. Journal of Molecular Neuroscience. 74(1). 7–7. 4 indexed citations
3.
Mulyana, Beni, et al.. (2024). Alteration of Cortical Somatosensory Feedback in Post-Stroke Movement Control. PubMed. 2024. 1–4.
4.
Karami, Hadi, et al.. (2023). Triggering of Endoplasmic Reticulum Stress by Tannic Acid Inhibits the Proliferation and Migration of Colorectal Cancer Cells. Asian Pacific Journal of Cancer Prevention. 24(8). 2705–2711. 6 indexed citations
5.
Darvish, Maryam. (2023). LncRNA FTH1P3: A New Biomarker for Cancer-Related Therapeutic Development. Current Molecular Medicine. 24(5). 576–584. 1 indexed citations
6.
Asghariazar, Vahid, et al.. (2022). Simvastatin-loaded PCL/PEG nanofibrous scaffold: A prospective approach for suppression 5-fluorouracil resistance in MKN-45 gastric cancer cells. Journal of Drug Delivery Science and Technology. 80. 104104–104104. 14 indexed citations
7.
Fath, Mohsen Karami, et al.. (2022). Circular RNAs in neuroblastoma: Pathogenesis, potential biomarker, and therapeutic target. Pathology - Research and Practice. 238. 154094–154094. 5 indexed citations
8.
Tarrahimofrad, Hossein, et al.. (2022). A designed peptide-based vaccine to combat Brucella melitensis, B. suis and B. abortus: Harnessing an epitope mapping and immunoinformatics approach. Biomedicine & Pharmacotherapy. 155. 113557–113557. 13 indexed citations
9.
Nahand, Javid Sadri, Mohammad Taghizadieh, Mohammad Saeid Ebrahimi, et al.. (2021). Oncogenic viruses and chemoresistance: What do we know?. Pharmacological Research. 170. 105730–105730. 33 indexed citations
10.
Davoodvandi, Amirhossein, Maryam Darvish, Sarina Borran, et al.. (2020). The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis. International Immunopharmacology. 88. 106905–106905. 53 indexed citations
11.
Ashrafizadeh, Milad, Zahra Bahmanpour, Ali Zarrabi, et al.. (2020). Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Frontiers in Chemistry. 8. 829–829. 85 indexed citations
12.
Pourhanifeh, Mohammad Hossein, et al.. (2020). Therapeutic role of curcumin and its novel formulations in gynecological cancers. Journal of Ovarian Research. 13(1). 130–130. 48 indexed citations
13.
Darvish, Maryam, et al.. (2019). Umbilical cord blood mesenchymal stem cells application in hematopoietic stem cells expansion on nanofiber three‐dimensional scaffold. Journal of Cellular Biochemistry. 120(7). 12018–12026. 21 indexed citations
14.
Darvish, Maryam, et al.. (2019). Improved bladder smooth muscle cell differentiation of the mesenchymal stem cells when grown on electrospun polyacrylonitrile/polyethylene oxide nanofibrous scaffold. Journal of Cellular Biochemistry. 120(9). 15814–15822. 11 indexed citations
15.
Mortazavi, Yousef, et al.. (2018). Ex Vivo Expansion of Umbilical Cord Blood Hematopoietic Stem Cells on Collagen- Fibronectin Coated Electrospun Nano Scaffold. Journal of Advances in Medical and Biomedical Research. 26(117). 32–43. 2 indexed citations
16.
Darvish, Maryam, et al.. (2016). Camelid antivenom development and potential in vivo neutralization of Hottentotta saulcyi scorpion venom. Toxicon. 113. 70–75. 13 indexed citations
17.
Darvish, Maryam, Mahdi Behdani, Mohammad Ali Shokrgozar, Kamran Pooshang Bagheri, & Delavar Shahbazzadeh. (2015). Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody. Molecular Immunology. 68(2). 412–420. 15 indexed citations
18.
Kadivar, Mehdi, Maryam Darvish, & Malihe Moghadam. (2009). ISOLATION, CULTURE AND CHARACTERIZATION OF HUMAN SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS. SHILAP Revista de lepidopterología. 11(242). 160–167. 1 indexed citations
19.
20.
Shapshak, Paul, W. W. Tourtellotte, S. Nakamura, et al.. (1985). Subacute sclerosing panencephalitis. Neurology. 35(11). 1605–1605. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoqin Yu Breakdown of academic impact, for papers by Noureldien H. E. Darwish Breakdown of academic impact, for papers by Mohsen Rastegari‐Pouyani Breakdown of academic impact, for papers by Anvar Soleimani Breakdown of academic impact, for papers by Jieping Wu Breakdown of academic impact, for papers by Jinghui Lu Breakdown of academic impact, for papers by Zheng Qiu Breakdown of academic impact, for papers by Alessandro Paolini Breakdown of academic impact, for papers by Qianqian Di Breakdown of academic impact, for papers by Sebastian Reichert
Rankless by CCL
2026